Aelis Farma Logo

Aelis Farma | AELIS - Profile, Filings, Stock Info & Investor Relations Data

Aelis Farma | AELIS
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Country
France
Founded
2013
Aelis Farma (AELIS)

Company Profile

About Aelis Farma

Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases.

Aelis Farma is developing a new class of drugs: Signaling Specific inhibitors of the CB1 receptor (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments.

These unique drug candidates, by reproducing a recently discovered natural defense mechanism of the brain , appear to be able to treat various brain pathologies without disrupting normal behavior. A first in pharmacology.

Employees

24

Headquarters

1 RUE LAFAURIE DE MONBADON
33000, BORDEAUX
France

Company Video

Video thumbnail
Click to load video from YouTube

Aelis Farma (AELIS)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Get Notified About Aelis Farma's New Filings

Receive email alerts when new documents are published.

You can unsubscribe at any time.

Aelis Farma (AELIS)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

Aelis Farma (AELIS)
Stock & Investor Information

ISINs

FR0014007ZB4

LEI

8945008D5R6WV7EXRN47

Stock Exchange Listings

Euronext Paris

Primary Stock Exchange Listing

View Aelis Farma on main exchange

Industry Classification